Sound Agriculture
Maker of SOURCE, a biological product that cuts synthetic nitrogen and phosphorus use on farms.
Sound Agriculture has a working product and real acreage, but it still leans on farmer incentives to drive adoption while a richer rival, Pivot Bio, sells into the same fields.
Sound Agriculture sells a soil treatment called SOURCE that uses microbes to help plants get nitrogen from the air instead of needing synthetic fertilizer. The company has real customers on 2 million acres and has government approval to sell the product, which are genuine advantages. However, after 12 years and nearly $200 million in investor money, the company is not making money and can only sell by paying farmers $10 per acre to try it and guaranteeing they will get better yields worth $100 per acre. The biggest question is whether farmers will keep buying once those payments disappear, or whether Pivot Bio, a better-funded competitor making similar microbe products, will outpace them first.
Structure of Sound's next financing round after the Dec 2024 raise. A new-lead up-round shows investor confidence; an insider-only extension shows weakness.
Whether Sound discloses profitability or revenue growth above $50M ARR within 12 months. Would confirm the company is reaching sustainable unit economics.
- SOURCE reached about 2M US farm acres in 4 years
- $25M Series D extension closed
- Total raised roughly $183M to $195M across 8 rounds
- Adoption still depends on $10/acre incentive plus $100/acre yield guarantee rather than full-price organic demand.
- Better-funded direct rival Pivot Bio (~$600M+ raised) targets the same nitrogen-efficiency buyers.
- No confirmed profitability after roughly 12 years and $183M to $195M raised as of March 2025.
- Latest disclosed raise was a $25M Series D extension in December 2024, not a fresh up-round from a new lead investor.
- Broader biological crop-input sector shows signs of investor caution around long-term viability.
| Rival | Direction | Evidence |
|---|---|---|
| Pivot Bio | gaining on | Raised $430M Series D in 2021 and over $600M lifetime vs Sound's $183M to $195M total (2025-01-14) |
| Bayer | contesting | Runs its own biologicals division while also investing in Sound via Leaps by Bayer, blurring rival vs backer role |
| Syngenta | contesting | Syngenta Ventures backed Sound since 2017 Series B while Syngenta's agrochemical arm competes in same nutrient-efficiency space |
| Kula Bio | contesting | Raised $10M seed in 2021 for competing nitrogen-fixing bacteria biofertilizer |
- Is Sound Agriculture profitable in 2026?
- Not confirmed. In its December 17, 2024 $25M raise announcement, Sound Agriculture said the funding was 'propelling it toward profitability,' implying it was not yet profitable at that date. No independent profitability disclosure has followed as of mid 2026.
- Who is Sound Agriculture's biggest competitor?
- Pivot Bio is the closest direct rival, targeting the same nitrogen-efficiency market with microbe-based fixation. Pivot Bio raised a $430M Series D in 2021 and has taken in over $600M lifetime, versus Sound Agriculture's estimated $183M to $195M total raised as of March 2025.
- Could AI replace Sound Agriculture's product?
- Unlikely for its core offering. SOURCE is a patented signaling-chemistry molecule requiring wet-lab discovery, EPA registration, and multi-year field trials, none of which software replicates. AI could pressure agronomic dosing recommendations, but the physical product and regulatory approval remain durable barriers.
- How much funding has Sound Agriculture raised?
- An estimated $183M to $195M across roughly seven to eight rounds as of March 4, 2025, per CB Insights, including a $75M Series D closed December 7, 2022 and a $25M Series D extension closed December 17, 2024 led by BMO Impact Investment Fund and S2G Ventures.
- Who owns Sound Agriculture?
- It is privately held and venture-backed, with no public listing. Investors include Syngenta Ventures, Leaps by Bayer, S2G Ventures, BMO Impact Investment Fund, Fall Line Capital, and the Chan Zuckerberg Initiative, per the company's December 17, 2024 funding announcement.
- What happened with Sound Agriculture's Decibel Bio spinout?
- In December 2024, Sound Agriculture spun out its plant-epigenetics platform into an independent company, Decibel Bio, led by co-founder Travis Bayer as CEO. Decibel Bio raised its own $12M seed round, publicly unveiled around March 6, 2025, from Breakthrough Energy Ventures, Future Ventures, Leaps by Bayer, and Syngenta.
- 2025-03-07Form D filing shows ongoing private securities activity after Dec 2024 raise
- 2025-03-06Decibel Bio epigenetics spinout publicly unveiled with $12M seed round
- 2024-12-17Sound Agriculture closes $25M Series D extension, cites path toward profitability
- 2024-12SOURCE reaches roughly 2 million acres of US farmland since 2020 launch
- 2022-12-07Sound Agriculture closes $75M Series D backed by Chan Zuckerberg Initiative
- 2021-01-28SOURCE extended to soybeans
- 2020-05Series C round of approximately $22M closes
- 2019-12-04SOURCE commercially launched, providing about 25 lbs/acre N and P equivalent
- 2018-09-19Asilomar Bio rebrands as Sound Agriculture Company
- 2017-12Series B round of $12.25M closes, led by Syngenta Ventures
- Asilomar Bio rebrands as Sound Agriculture (2018-09-19)
- Sound Agriculture's Differentiated Science and Mission-Driven Team Drives the Biologicals Business (2019-07-02)
- Pivot Bio scores $430m in DCVC, Temasek-led Series D round (2025-01-14)
- Sound Agriculture nets $75M from Chan Zuckerberg Initiative, others (2022-12-07)
- Sound Agriculture Secures $25M to Advance Bioinspired Nutrient Efficiency Solutions (2024-12-17)
- Sound Agriculture Stock Price, Funding, Valuation, Revenue & Financial Statements (2025-03-04)
- Sound Agriculture: Employee Directory (2024-02-01)
- This Gates-backed startup can fine-tune plants for specific purposes without ever touching their genes (2025-03-06)
- Revenue, Competitors, Alternatives (2022-04-19)
- Sound Agriculture Overview, Address & Contact (2025-01-16)
- Sound Agriculture secures an additional $25m (2025-01-14)
- Products, Competitors, Financials... (2025-02-27)